These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30237271)

  • 1. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
    Leivonen SK; Pollari M; Brück O; Pellinen T; Autio M; Karjalainen-Lindsberg ML; Mannisto S; Kellokumpu-Lehtinen PL; Kallioniemi O; Mustjoki S; Leppä S
    Haematologica; 2019 Feb; 104(2):338-346. PubMed ID: 30237271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1
    Pollari M; Brück O; Pellinen T; Vähämurto P; Karjalainen-Lindsberg ML; Mannisto S; Kallioniemi O; Kellokumpu-Lehtinen PL; Mustjoki S; Leivonen SK; Leppä S
    Haematologica; 2018 Nov; 103(11):1908-1914. PubMed ID: 30026337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
    Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S
    Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone.
    Rajnai H; Heyning FH; Koens L; Sebestyén A; Andrikovics H; Hogendoorn PC; Matolcsy A; Szepesi Á
    Virchows Arch; 2014 Feb; 464(2):229-39. PubMed ID: 24306958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors.
    Chovanec M; Cierna Z; Miskovska V; Machalekova K; Kalavska K; Rejlekova K; Svetlovska D; Macak D; Spanik S; Kajo K; Babal P; Mego M; Mardiak J
    BMC Cancer; 2018 Nov; 18(1):1062. PubMed ID: 30390643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
    Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
    Front Immunol; 2020; 11():550250. PubMed ID: 33193316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.
    Gullo I; Oliveira P; Athelogou M; Gonçalves G; Pinto ML; Carvalho J; Valente A; Pinheiro H; Andrade S; Almeida GM; Huss R; Das K; Tan P; Machado JC; Oliveira C; Carneiro F
    Gastric Cancer; 2019 Jan; 22(1):77-90. PubMed ID: 29779068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma.
    Autio M; Leivonen SK; Brück O; Mustjoki S; Mészáros Jørgensen J; Karjalainen-Lindsberg ML; Beiske K; Holte H; Pellinen T; Leppä S
    Haematologica; 2021 Mar; 106(3):718-729. PubMed ID: 32079690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
    Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
    Front Immunol; 2021; 12():657950. PubMed ID: 33936088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
    Li L; Sun R; Miao Y; Tran T; Adams L; Roscoe N; Xu B; Manyam GC; Tan X; Zhang H; Xiao M; Tzankov A; Visco C; Dybkaer K; Bhagat G; Tam W; Hsi ED; van Krieken JH; You H; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Zhang M; Winter JN; Medeiros LJ; Rassidakis GZ; Vaupel CA; Li Y; Dakappagari N; Xu-Monette ZY; Young KH
    Mod Pathol; 2019 Jun; 32(6):741-754. PubMed ID: 30666052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon Cancer-May Cold Tumors Simply Be Too Hot?
    Køstner AH; Nielsen PS; Georgsen JB; Parner ET; Nielsen MB; Kersten C; Steiniche T
    Front Immunol; 2021; 12():716342. PubMed ID: 34531864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
    Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I
    Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low PD-1 Expression in Cytotoxic CD8
    Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
    Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
    Shen Y; Guan Y; Hummel JJ; Shyu CR; Mitchem JB
    BMC Cancer; 2020 Feb; 20(1):124. PubMed ID: 32059711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
    Hu Y; Cui M; Bi Y; Zhang X; Wang M; Hua S; Liao Q; Zhao Y
    J Endocrinol Invest; 2020 Oct; 43(10):1453-1461. PubMed ID: 32219691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.